Association of cardiovascular disease and urate levels with aortic aneurysm: a bilateral mendelian randomization

Yuanyuan Xiao1, Tao Xiang2,3

  • 1Department of Emergency, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.

Scientific Reports
|October 14, 2024
PubMed

Insights

Coronary artery disease and myocardial infarction causally increase the risk of aortic aneurysm and abdominal aortic aneurysm. No causal link was found between these conditions and thoracic aortic aneurysm or urate levels.

Area of Science:

  • Cardiovascular Genetics
  • Aortic Diseases
  • Epidemiology

Background:

  • Coronary artery disease (CAD) and myocardial infarction (MI) are leading causes of mortality worldwide.
  • Aortic aneurysms (AA), including abdominal (AAA) and thoracic (TAA) types, and aortic dissection (AD) represent serious vascular conditions.
  • The etiological relationship between CAD/MI and various aortic pathologies, including urate levels, remains incompletely understood.

Purpose of the Study:

  • To investigate potential causal relationships between coronary artery disease (CAD), myocardial infarction (MI), and urate levels with aortic aneurysm (AA), abdominal aortic aneurysm (AAA), thoracic aortic aneurysm (TAA), and aortic dissection (AD).
  • To employ Mendelian randomization (MR) to assess these causal links in individuals of European ancestry.

Main Methods:

  • Two-sample Mendelian randomization (MR) analysis using genome-wide association study (GWAS) data for CAD, MI, and urate levels.
  • Genetic instruments for AA, AAA, TAA, and AD were sourced from the FinnGen cohort.
  • Primary analysis utilized the inverse-variance weighted (IVW) method, with sensitivity analyses including MR-Egger, weighted median MR, and MR-PRESSO; MR-Egger intercept and Cochran's Q statistics assessed pleiotropy and heterogeneity, respectively. Bidirectional MR was performed to address reverse causation.

Main Results:

  • A statistically significant positive causal relationship was identified between CAD/MI and the risk of AA (OR: 1.309; 95% CI: 1.150-1.490) and AAA (OR: 1.383; 95% CI: 1.189-1.609).
  • Sensitivity analyses confirmed the robustness of these findings.
  • No significant causal links were observed between CAD, MI, urate levels, and TAA or AD.

Conclusions:

  • CAD and MI are established causal risk factors for the development of AA and AAA.
  • The findings suggest that interventions targeting CAD/MI risk factors may also benefit aortic health.
  • Urate levels and CAD/MI do not appear to have a causal role in TAA development.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
3
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
3
Atherosclerosis II: Clinical manifestations and prevention01:27

Atherosclerosis II: Clinical manifestations and prevention

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
2
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
3
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.1K